We are live on ! Find out more
ARCT icon

Arcturus Therapeutics

127 hedge funds and large institutions have $783M invested in Arcturus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 28

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

64% more call options, than puts

Call options by funds: $27M | Put options by funds: $16.5M

29% more capital invested

Capital invested by funds: $606M → $783M (+$177M)

11.48% more ownership

Funds ownership: 63.2%74.68% (+11%)

11% more funds holding

Funds holding: 114127 (+13)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
127
Holders Change
+13
Holders Change %
+11.4%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
33
Increased
54
Reduced
28
Closed
20
Calls
$27M
Puts
$16.5M
Net Calls
+$10.6M
Net Calls Change
+$14.5M
Name Holding Trade Value Shares
Change
Change in
Stake
SCA
76
Snowden Capital Advisors
New York
$521K +$603K +12,154 New
New York State Common Retirement Fund
77
New York State Common Retirement Fund
New York
$515K
Man Group
78
Man Group
United Kingdom
$512K +$592K +11,924 New
Wolverine Trading
79
Wolverine Trading
Illinois
$511K -$403K -8,115 -40%
DC
80
Diametric Capital
Massachusetts
$440K -$61.1K -1,230 -11%
Deutsche Bank
81
Deutsche Bank
Germany
$438K -$25.4M -511,470 -98%
CSS
82
Cubist Systematic Strategies
Connecticut
$427K -$1.07M -21,638 -68%
SM
83
SG3 Management
Puerto Rico
$416K +$481K +9,697 New
AIG
84
American International Group
New York
$411K +$79.1K +1,594 +20%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$377K +$60.8K +1,224 +16%
Barclays
86
Barclays
United Kingdom
$371K -$1.14M -22,974 -73%
State Board of Administration of Florida Retirement System
87
State Board of Administration of Florida Retirement System
Florida
$363K +$49.1K +990 +13%
Invesco
88
Invesco
Georgia
$362K -$10.5M -212,490 -96%
E
89
Ergoteles
New York
$344K +$398K +8,020 New
VOYA Investment Management
90
VOYA Investment Management
Georgia
$330K +$159K +3,203 +71%
Marshall Wace
91
Marshall Wace
United Kingdom
$330K +$382K +7,689 New
VRS
92
Virginia Retirement Systems
Virginia
$309K +$357K +7,200 New
MIM
93
MetLife Investment Management
New Jersey
$304K +$51.6K +1,040 +17%
BAM
94
Blueshift Asset Management
New Jersey
$278K +$322K +6,477 New
ASRS
95
Arizona State Retirement System
Arizona
$247K +$286K +5,762 New
PCM
96
Prelude Capital Management
New York
$246K -$103K -2,073 -27%
JCM
97
JS Capital Management
New York
$245K +$283K +5,700 New
CG
98
Cutler Group
California
$244K +$92.5K +1,864 +49%
TCM
99
Traynor Capital Management
Pennsylvania
$243K +$245K +4,939 New
DCM
100
Dupont Capital Management
Delaware
$235K +$272K +5,478 New

ARCT Hedge Fund Activity: Q3 2020 in Review

127 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q3 2020, worth a combined $783M — up 29% from $606M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ARCT positions and 20 closed out — a net gain of 13 holders — while 54 added to existing stakes and 28 trimmed.

The largest buyer was HealthCor Management, adding an estimated $74.5M. The largest seller was Deutsche Bank, cutting an estimated $25.4M.

  • 127 institutional investors held Arcturus Therapeutics (ARCT) as of Q3 2020, up from 114 in Q2 2020.
  • Funds reported $783M of Arcturus Therapeutics stock for Q3 2020, up 29% quarter-over-quarter.
  • 33 funds opened new Arcturus Therapeutics positions in Q3 2020 and 20 closed out, a net change of +13 holders.
  • The largest Arcturus Therapeutics buyer in Q3 2020 was HealthCor Management, an estimated $74.5M added.
  • The largest Arcturus Therapeutics seller in Q3 2020 was Deutsche Bank, an estimated $25.4M sold.

Based on aggregated 13F filings for Q3 2020.